| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 15 |
| 1 | ETOPOSIDE | 15 |
| 2 | MITOXANTRONE | 12 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 12 |
| 4 | CARBOPLATIN | 11 |
| 5 | CYCLOPHOSPHAMIDE | 11 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| 8 | MELPHALAN HYDROCHLORIDE | 11 |
| 9 | IFOSFAMIDE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOXANTRONE HYDROCHLORIDE | 12 | 0.0019 |
| 1 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 2 | IFOSFAMIDE FOR INJECTION | 10 | 0.0005 |
| 3 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0005 |
| 4 | MELPHALAN HYDROCHLORIDE | 11 | 0.0004 |
| 5 | ETOPOSIDE | 15 | 0.0002 |
| 6 | CISPLATIN | 15 | 0.0002 |
| 7 | PHENTERMINE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | FOSTAMATINIB | 1 | 0.0001 |
| 9 | OZANIMOD HYDROCHLORIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |
| 1 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 16 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 12 | 0.0000 |
| 4 | Recombinant Human Growth Hormone [EPC] | 1 | 0.0000 |
| 5 | Proteasome Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 7 | Catecholamine [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 9 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |